These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 39269961

  • 21. Improving methadone access for rural communities in the USA: lessons learned from COVID-19 adaptations and international models of care.
    Lister JJ, Lister HH.
    Rural Remote Health; 2021 Nov; 21(4):6770. PubMed ID: 34757760
    [Abstract] [Full Text] [Related]

  • 22. The COVID-19 pandemic and opioid use disorder: Expanding treatment with buprenorphine, and combining safety precautions with telehealth.
    Cales RH, Cales SC, Shreffler J, Huecker MR.
    J Subst Abuse Treat; 2022 Feb; 133():108543. PubMed ID: 34210567
    [Abstract] [Full Text] [Related]

  • 23. A novel transition: Lessons learned during rapid implementation and evolution of telehealth group based opioid treatment (t-GBOT) during the COVID-19 pandemic.
    Sokol R, Suter S, Pierce B, Council L, Grossman E, Roland L, Roll D, Mintzer E.
    Healthc (Amst); 2021 Sep; 9(3):100559. PubMed ID: 34052621
    [No Abstract] [Full Text] [Related]

  • 24. Mobile Telemedicine for Buprenorphine Treatment in Rural Populations With Opioid Use Disorder.
    Weintraub E, Seneviratne C, Anane J, Coble K, Magidson J, Kattakuzhy S, Greenblatt A, Welsh C, Pappas A, Ross TL, Belcher AM.
    JAMA Netw Open; 2021 Aug 02; 4(8):e2118487. PubMed ID: 34448869
    [Abstract] [Full Text] [Related]

  • 25. Perceived impact of COVID-19 on prevention, treatment, harm reduction, and recovery services for opioid use disorder: National survey of local health departments.
    Swann WL, Schreiber TL, Kim SY, McNeely H, Hong JH.
    Subst Abus; 2022 Aug 02; 43(1):993-998. PubMed ID: 35435800
    [Abstract] [Full Text] [Related]

  • 26. "Double whammy": a rapid review of rural vs urban psychosocial cancer experiences and telehealth service in five countries during the COVID-19 pandemic.
    Barnes M, Rice K, Murray C, Thorsteinsson E.
    PeerJ; 2022 Aug 02; 10():e14382. PubMed ID: 36438575
    [Abstract] [Full Text] [Related]

  • 27. Gender differences in receipt of telehealth versus in person behavioral therapy, medication for opioid use disorder (MOUD), and 90-day MOUD retention during the pandemic: A retrospective veteran cohort study.
    Livingston NA, Sarpong A, Sistad R, Roth C, Banducci AN, Simpson T, Hyde J, Davenport M, Weisberg R.
    J Subst Use Addict Treat; 2024 Jan 02; 156():209188. PubMed ID: 37866437
    [Abstract] [Full Text] [Related]

  • 28. Rural-urban disparities in knowledge, behaviors, and mental health during COVID-19 pandemic: A community-based cross-sectional survey.
    Zhang J, Zhu L, Li S, Huang J, Ye Z, Wei Q, Du C.
    Medicine (Baltimore); 2021 Apr 02; 100(13):e25207. PubMed ID: 33787602
    [Abstract] [Full Text] [Related]

  • 29. Designing and Evaluating COVID-19 Protocols for an Office-Based Opioid Treatment Program in an Urban Underserved Setting.
    O'Gurek DT.
    J Am Board Fam Med; 2021 Feb 02; 34(Suppl):S136-S140. PubMed ID: 33622828
    [Abstract] [Full Text] [Related]

  • 30. Residence in urban or rural counties in relation to opioid overdose mortality among Kentucky hospitalizations before and during the COVID-19 pandemic.
    Blair LK, Howard J, Peiper NC, Little BB, Taylor KC, Baumgartner R, Creel L, DuPre NC.
    Int J Drug Policy; 2023 Sep 02; 119():104122. PubMed ID: 37473677
    [Abstract] [Full Text] [Related]

  • 31. Can You Hear Me Now? Patient Perceptions of Telehealth in a Rural Primary Care Population.
    Charlly N, Swedlund M.
    Telemed J E Health; 2024 Jun 02; 30(6):e1719-e1726. PubMed ID: 38452338
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Rates of Primary Care and Integrated Mental Health Telemedicine Visits Between Rural and Urban Veterans Affairs Beneficiaries Before and After the Onset of the COVID-19 Pandemic.
    Leung LB, Yoo C, Chu K, O'Shea A, Jackson NJ, Heyworth L, Der-Martirosian C.
    JAMA Netw Open; 2023 Mar 01; 6(3):e231864. PubMed ID: 36881410
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Telehealth sustains patient engagement in OUD treatment during COVID-19.
    Langabeer JR, Yatsco A, Champagne-Langabeer T.
    J Subst Abuse Treat; 2021 Mar 01; 122():108215. PubMed ID: 33248863
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Telemedicine Use and Quality of Opioid Use Disorder Treatment in the US During the COVID-19 Pandemic.
    Hailu R, Mehrotra A, Huskamp HA, Busch AB, Barnett ML.
    JAMA Netw Open; 2023 Jan 03; 6(1):e2252381. PubMed ID: 36692880
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.